Self-optimisation of the final stage in the synthesis of EGFR kinase inhibitor AZD9291 using an automated flow reactor

Holmes, Nicholas and Akien, Geoffrey Richard and Blacker, A. John and Woodward, Robert L. and Meadows, Rebecca E. and Bourne, Richard A. (2016) Self-optimisation of the final stage in the synthesis of EGFR kinase inhibitor AZD9291 using an automated flow reactor. Reaction Chemistry and Engineering, 1 (4). pp. 366-371. ISSN 2058-9883

Full text not available from this repository.

Abstract

Self-optimising flow reactors combine online analysis with evolutionary feedback algorithms to rapidly achieve optimum conditions. This technique has been applied to the final bond-forming step in the synthesis of AZD9291, an irreversible epidermal growth factor receptor kinase inhibitor developed by AstraZeneca. A four parameter optimisation of a telescoped amide coupling followed by an elimination reaction was achieved using at-line high performance liquid chromatography. Optimisations were initially carried out on a model compound (2,4-dimethoxyaniline) and the data used to track the formation of various impurities and ultimately propose a mechanism for their formation. Our protocol could then be applied to the optimisation of the 2-step telescoped reaction to synthesise AZD9291 in 89% yield.

Item Type:
Journal Article
Journal or Publication Title:
Reaction Chemistry and Engineering
ID Code:
84646
Deposited By:
Deposited On:
09 Feb 2017 09:32
Refereed?:
Yes
Published?:
Published
Last Modified:
01 Sep 2020 03:46